comparemela.com

Latest Breaking News On - Senior officer stephen richard losty - Page 1 : comparemela.com

Desjardins Cuts Neighbourly Pharmacy (TSE:NBLY) Price Target to C$18 50

Neighbourly Pharmacy (TSE:NBLY – Free Report) had its price target lowered by Desjardins from C$20.00 to C$18.50 in a research report report published on Wednesday, BayStreet.CA reports. Desjardins currently has a hold rating on the stock. A number of other equities research analysts also recently weighed in on the company. National Bankshares reduced their target […]

Desjardins Lowers Neighbourly Pharmacy (TSE:NBLY) Price Target to C$18 50

Neighbourly Pharmacy (TSE:NBLY – Free Report) had its target price cut by Desjardins from C$20.00 to C$18.50 in a report issued on Wednesday morning, BayStreet.CA reports. They currently have a hold rating on the stock. A number of other research firms also recently issued reports on NBLY. BMO Capital Markets lifted their price objective on […]

Neighbourly Pharmacy (TSE:NBLY) Downgraded to Sector Perform at TD Securities

TD Securities cut shares of Neighbourly Pharmacy (TSE:NBLY – Free Report) from an outperform rating to a sector perform rating in a report released on Wednesday morning, BayStreet.CA reports. TD Securities currently has C$18.50 target price on the stock, down from their prior target price of C$28.00. A number of other research analysts have also […]

Neighbourly Pharmacy (TSE:NBLY) Lowered to Sector Perform at TD Securities

Neighbourly Pharmacy (TSE:NBLY – Get Free Report) was downgraded by research analysts at TD Securities from an “outperform” rating to a “sector perform” rating in a research note issued to investors on Wednesday, BayStreet.CA reports. They currently have a C$18.50 price objective on the stock, down from their prior price objective of C$28.00. TD Securities’ […]

Neighbourly Pharmacy Inc (TSE:NBLY) Given Consensus Recommendation of Moderate Buy by Brokerages

Neighbourly Pharmacy Inc. (TSE:NBLY – Get Free Report) has been given an average recommendation of “Moderate Buy” by the five analysts that are presently covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 1-year target […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.